The relationship between ACE polymorphisms and COVID-19 suggests that public health institutions should further strengthen the prevention for patients with the DD genotypes, and medical institutions need to carefully assess the progression of COVID-19 patients with the DD genotypes. The gene discussed is ACE; the disease is COVID-19.